Skip to content
1 - /townhall/Kasich1/ -- Capitol Hill Town Hall Series
TRENDING:
Advertisement

Newly-released inmate George Ballentine holds his prescription medicine Suboxone outside a pharmacy on July 23, 2018, in Greenfield, Mass. The attorneys general for 41 states and the District of Columbia announced a $102.5 million settlement Friday, June 2, 2023, with Suboxone maker Indivior Inc., over claims that the company schemed to keep generic competitors off the market. Suboxone, a branded version of buprenorphine and naloxone, is used to treat opioid addiction. (AP Photo/Elise Amendola) **FILE**

Newly-released inmate George Ballentine holds his prescription medicine Suboxone outside a pharmacy on July 23, 2018, in Greenfield, Mass. The attorneys general for 41 states and the District of Columbia announced a $102.5 million settlement Friday, June 2, 2023, with Suboxone maker Indivior Inc., over claims that the company schemed to keep generic competitors off the market. Suboxone, a branded version of buprenorphine and naloxone, is used to treat opioid addiction. (AP Photo/Elise Amendola) **FILE**

Featured Photo Galleries